摘要
背景:抗菌素耐药(AMR)对全球公众健康构成严重威胁,需要立即采取行动,最好是长期。目前的药物疗法无法遏制这种威胁,因为微生物能够规避药物的作用机制。从药物发现的角度来看,目前用于抗菌治疗的大多数药物都是小分子。最近的趋势显示使用肽作为候选药物的激增,因为它们比小分子具有显着的优势。 方法:较新的合成策略,如有机金属配合物,肽 - 聚合物结合物,固相,液相和重组DNA技术,鼓励使用肽作为具有许多化学功能的治疗剂,并针对特定应用量身定制。在过去的十年中,许多基于肽的药物已经被食品和药物管理局(FDA)成功地批准。这种成功可归因于它们的高特异性,选择性和功效,对组织的高渗透性,较低的免疫原性和较少的组织积累。考虑到AMR的巨大性,使用抗菌肽(AMPs)可以成为当前治疗策略的可行替代方案。 AMPs天然丰富,可以让合成化学家开发半合成肽分子。 AMP对微生物具有广泛的活性,并且具有绕过微生物的抗性诱导机制的能力。 结果:本综述重点讨论AMPs对各种微生物疾病及其未来前景的潜在应用。还讨论了几个抵制机制及其战略,以突出当前情况下的重要性。 结论:AMP设计,肽合成和生物技术方面的突破已经显示出应对这一挑战的希望,并重新激活了使用AMPs作为抗击AMR的重要武器的兴趣。
关键词: 抗微生物性,抗微生物性,多肽性,发展性,抗性机理,抗攻击性
Current Medicinal Chemistry
Title:Antimicrobial Peptides: A Promising Therapeutic Strategy in Tackling Antimicrobial Resistance
Volume: 24 Issue: 38
关键词: 抗微生物性,抗微生物性,多肽性,发展性,抗性机理,抗攻击性
摘要: Background: Antimicrobial resistance (AMR) has posed a serious threat to global public health and it requires immediate action, preferably long term. Current drug therapies have failed to curb this menace due to the ability of microbes to circumvent the mechanisms through which the drugs act. From the drug discovery point of view, the majority of drugs currently employed for antimicrobial therapy are small molecules. Recent trends reveal a surge in the use of peptides as drug candidates as they offer remarkable advantages over small molecules.
Methods: Newer synthetic strategies like organometalic complexes, Peptide-polymer conjugates, solid phase, liquid phase and recombinant DNA technology encouraging the use of peptides as therapeutic agents with a host of chemical functions, and tailored for specific applications. In the last decade, many peptide based drugs have been successfully approved by the Food and Drug Administration (FDA). This success can be attributed to their high specificity, selectivity and efficacy, high penetrability into the tissues, less immunogenicity and less tissue accumulation. Considering the enormity of AMR, the use of Antimicrobial Peptides (AMPs) can be a viable alternative to current therapeutics strategies. AMPs are naturally abundant allowing synthetic chemists to develop semi-synthetics peptide molecules. AMPs have a broad spectrum of activity towards microbes and they possess the ability to bypass the resistance induction mechanisms of microbes.
Result: The present review focuses on the potential applications of AMPs against various microbial disorders and their future prospects. Several resistance mechanisms and their strategies have also been discussed to highlight the importance in the current scenario.
Conclusion: Breakthroughs in AMP designing, peptide synthesis and biotechnology have shown promise in tackling this challenge and has revived the interest of using AMPs as an important weapon in fighting AMR.
Export Options
About this article
Cite this article as:
Antimicrobial Peptides: A Promising Therapeutic Strategy in Tackling Antimicrobial Resistance, Current Medicinal Chemistry 2017; 24 (38) . https://dx.doi.org/10.2174/0929867324666170815102441
DOI https://dx.doi.org/10.2174/0929867324666170815102441 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Role of mTOR in Hematological Malignancies
Current Cancer Therapy Reviews Relationship with Metalloproteinase 13, E-cadherin, Homocysteine and Co Factors Folic Acid and Vitamin B12 in Patients Diagnosed with Prostate Cancer
Current Enzyme Inhibition Novel Target Sites for Drug Screening: A Special Reference to Cancer, Rheumatoid Arthritis and Parkinson’s Disease
Current Signal Transduction Therapy The Central Role Played by Peptides in the Immune Response and the Design of Peptide-Based Vaccines Against Infectious Diseases and Cancer
Current Drug Targets Targeting the mTOR Pathway in Tumor Malignancy
Current Cancer Drug Targets Current Progress in Sample Preparation for Two-Dimensional Electrophoresis in Proteomics
Current Proteomics Fluorescent Probes for the Detection of Hydrogen Peroxide in Biological Systems
Current Organic Chemistry The Role of Dietary Fats in Hypertension, Obesity and Insulin Resistance: A Comparative Study of Animals and Humans in Fetal and Adult Life
Current Nutrition & Food Science Retinoic Acid Metabolism and Mechanism of Action: A Review
Current Drug Metabolism Bcl-2 Family Proteins Regulate Apoptosis and Epithelial to Mesenchymal Transition by Calcium Signals
Current Pharmaceutical Design Synthesis of Oleanolic Acid Analogues and Their Cytotoxic Effects on 3T3 Cell Line
Medicinal Chemistry Bisphosphonate Therapy for Patients with Breast Cancer
Current Cancer Therapy Reviews Fibroblast Growth Factors in Development and Cancer: Insights from the Mammary and Prostate Glands
Current Drug Targets The role of vitamin D towards immune tolerance in white adipose tissue (WAT)
Endocrine, Metabolic & Immune Disorders - Drug Targets Systemic Approach to the Study of Complex Bone Disorders at the Whole- Genome Level
Current Genomics Obstructive Sleep Apnoea Syndrome and Diabetes. Fortuitous Association or Interaction?
Current Diabetes Reviews Efficient Production of Gossypol from Hairy Root Cultures of Cotton (Gossypium hirsutum L.)
Current Pharmaceutical Biotechnology Should the Incorporation of Structural Alerts be Restricted in Drug Design? An Analysis of Structure-Toxicity Trends with Aniline-Based Drugs
Current Medicinal Chemistry Mood and Anxiety Disorders in Breast Cancer: An Update
Current Psychiatry Reviews Immunophilin Chaperones in Steroid Receptor Signalling
Current Topics in Medicinal Chemistry